A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer
Cancer Medicine · 2024
DOI: 10.1002/cam4.70103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Jana Soukupova und 51 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague…. Hauptthemen laut MEDLINE: Germ-Line Mutation, Genetic Predisposition to Disease, Breast Neoplasms, Ovarian Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo Školství, Mládeže a Tělovýchovy, Ministerstvo Zdravotnictví České Republiky, Grantová Agentura, Univerzita Karlova.
Abstract (Originalsprache)
Background
Monoallelic germline pathogenic variants (GPVs) in five Fanconi anemia (FA) genes ( BRCA1/FANCS , BRCA2/FANCD1 , PALB2/FANCN , BRIP1/FANCJ , and RAD51C/FANCO ) confer an increased risk of breast (BC) and/or ovarian (OC) cancer, but the role of GPVs in 17 other FA genes remains unclear.
Methods
Here, we investigated the association of germline variants in FANCG/XRCC9 with BC and OC risk.
Results
The frequency of truncating GPVs in FANCG did not differ between BC (20/10,204; 0.20%) and OC (8/2966; 0.27%) patients compared to controls (6/3250; 0.18%). In addition, only one out of five tumor samples showed loss‐of‐heterozygosity of the wild‐type FANCG allele. Finally, none of the nine functionally tested rare recurrent missense FANCG variants impaired DNA repair activities (FANCD2 monoubiquitination and FANCD2 foci formation) upon DNA damage, in contrast to all tested FANCG truncations.
Conclusion
Our study suggests that heterozygous germline FANCG variants are unlikely to contribute to the development of BC or OC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- Laboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.
- Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic.
- Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
- Centre for Medical Genetics and Reproductive Medicine, GENNET, Prague, Czech Republic.
ORCID-Profile: Libor Macurek, Zdenek Kleibl
Förderung
- Ministerstvo Školství, Mládeže a Tělovýchovy
- Ministerstvo Zdravotnictví České Republiky
- Grantová Agentura, Univerzita Karlova
- Ministerstvo Zdravotnictví Ceské Republiky
Zitieren
APA
Soukupova, J., Stastna, B., Kanwal, M., Hojny, J., Zemankova, P., Borecka, M., Cerna, L., Cerna, M., Cerna, M., Curtisova, V., Dolezalova, T., Duskova, P., Foretova, L., Havranek, O., Horackova, K., Hovhannisyan, M., Hruskova, L., Chvojka, S., Janatova, M., …, & CZECANCA consortium (2024). A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer. Cancer Medicine. https://doi.org/10.1002/cam4.70103
Vancouver
Soukupova J, Stastna B, Kanwal M, Hojny J, Zemankova P, Borecka M, et al. A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer. Cancer Medicine. 2024. doi:10.1002/cam4.70103
BibTeX
@article{Soukupova2024,
author = {Soukupova, Jana and Stastna, Barbora and Kanwal, Madiha and Hojny, Jan and Zemankova, Petra and Borecka, Marianna and Cerna, Leona and Cerna, Marta and Cerna, Monika and Curtisova, Vaclava and Dolezalova, Tatana and Duskova, Petra and Foretova, Lenka and Havranek, Ondrej and Horackova, Klara and Hovhannisyan, Milena and Hruskova, Lucie and Chvojka, Stepan and Janatova, Marketa and Janikova, Maria and Jelinkova, Sandra and Just, Pavel and Kalousova, Marta and Kleiblova, Petra and Kosarova, Marcela and Koudova, Monika and Kral, Jan and Krausova, Michaela and Krutilkova, Vera and Machackova, Eva and Matejkova, Katerina and Michalovska, Renata and Nehasil, Petr and Nemcova, Barbora and Novotny, Jan and Palek, Matous and Pesek, Pavel and Safarikova, Marketa and Scheinost, Ondrej and Springer, Drahomira and Stolarova, Lenka and Stranecky, Viktor and Subrt, Ivan and Tavandzis, Spiros and Tureckova, Eva and Vesela, Kamila and Vlckova, Zdenka and Vocka, Michal and Zima, Tomas and Macurek, Libor and Kleibl, Zdenek and CZECANCA consortium, CZECANCA consortium},
title = {A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.70103}
}
EUVIMED